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Summary 
Most mature B lymphocytes coexpress two classes of antigen receptor, immunoglobulin (Ig)M 
and IgD.  The differences in the signal transduction from the two receptors are still a matter 
of controversy. We have analyzed B cell lines expressing IgM or IgD antigen receptors with 
the same antigen specificity. Cross-linking of these receptors with either antigen, or class-specific 
antibodies, results in the activation of protein tyrosine kinases and the phosphorylation of the 
same substrate proteins. The kinetic and the intensity of phosphorylation, however, was quite 
different between the two receptors when they were cross-linked by antigen. In membrane IgM- 
expressing cells, the substrate phosphorylation reached a maximum after 1 minute and diminished 
after 60 minutes whereas, in the membrane IgD-expressing cells, the substrate phosphorylation 
increased further over time, reached its maximum at 60 minutes,  and persisted longer than 240 
minutes after exposure to antigen. As a result, the intensity of protein tyrosine phosphorylation 
induced by cross-linking of membrane IgD was stronger than that induced by membrane IgM. 
Studies of chimeric receptors demonstrate that only the membrane-proximal  C domain and/or 
the transmembrane part of membrane-bound IgD molecule is required for the long-lasting substrate 
phosphorylation. Together, these data suggest that the signal emission from the two receptors 
is controlled differently. 
T 
he B cell antigen receptor (BCK) t is a complex con- 
taining the membrane-bound immunoglobulin (mlg) 
molecule and the Ig-odlg-fl heterodimer (for reviews  see refer- 
ences 1-4).  Ig-ot and Ig-fl are glycosylated transmembrane 
proteins encoded by the B cell-specific genes mb-1 and B29, 
respectively (5, 6). Signal transduction from the cross-linked 
BCR involves the rapid activation of two types of protein 
tyrosine kinases (PTK); the src-related PTKs Lyn, Fyn, Lck, 
and Blk (7-9) (for review see reference 10) as well as the cy- 
toplasmic PTK Syk/PTK72 (11-14). These enzymes phos- 
phorylate several substrate proteins in B cells, including the 
BCR components Ig-ot and Ig-fl (15). The Ig-odlg-fl het- 
erodimer plays an important role in the activation of these 
PTKs (16-22) and, after its tyrosine phosphorylation, becomes 
a target for src-homology-2-carrying proteins  (23-25). 
All classes of mlg are associated with the Ig-ot/Ig-fl het- 
erodimer (26). The molecular weight of the mlgD-associated 
Ig-ot (IgD-cr) is larger than the mlgM-associated  Ig-ot (IgM-c  0 
1 Abbreviations used in this paper: BAP, BCR-associated  proteins; BCR, B 
cell antigen  receptor;  ECL, enhanced  chemiluminescence;  EGFR, epidermal 
growth factor receptor; mlg, membrane-bound  immunoglobulin;  EV, 
enhancer + V-promotor;  NGFR, neuronal  growth  factor  receptor;  NIP, 
4-hydroxy-3-iodo-5-nitrophenyl;  PTK, protein tyrosine  kinases; TKR, 
tyrosine kinase receptors. 
(27, 28). This size difference is due to an altered glycosyla- 
tion of the extracellular domains of these proteins (26, 27). 
The cytoplasmic parts of the Ig-ot/Ig-fl heterodimer, how- 
ever, are identical in the two BCR complexes. As the mlgM 
and mlgD molecules also have the same short cytoplasmic 
sequence (KVK), both BCR classes should be the same on 
the cytoplasmic side and, thus, are expected to communicate 
with the same intracellular  molecules. 
Most mature B ceils coexpress the IgM-BCR and IgD- 
BCR on their cell surfaces. Whether the two BCR classes 
have different functions on B cells is a matter of controversy. 
Several studies suggest that the engagement of mlgM and 
mlgD induces similar B cell responses (28-30).  This holds 
true for the early biochemical responses involving the activa- 
tion of PTK (31, 32) and the hydrolysis ofinositol phospho- 
lipids (33, 34). Other studies, however, show that mlgM, 
but not mlgD, can induce negative responses in B cells, such 
as anergy and apoptosis (35-40).  The IgD knockout mice 
do not show a severe immunodeficiency, which suggests at 
least a partial redundancy in the function ofmlgD and mlgM 
(41, 42). 
The two BCR classes are heterogeneously  expressed on 
normal mature B cells with IgD-BCR generally being more 
abundant than IgM-BCR. To compare the signaling func- 
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Volume 181  March  1995  1005-1014 tion of these receptors we chose Ig-transfectants of J558L as 
an antigen-specific and homogenous cell population. J558L 
cells produce Ig-/~ protein and X1 light chain,  but neither 
Ig-oe protein, nor Ig heavy chain (43, 44). After transfection 
with expression vectors for the Ig-oe protein and for heavy 
chains carrying the B1-8 VH domain, these cells express on 
their surfaces large amounts of BCR with specificity for the 
hapten  4-hydroxy-3-iodo-5-nitrophenyl  (NIP).  Although 
these myeloma cells lack several B cell surface markers,  in- 
cluding CD19,  CD22,  CD40,  and CD45,  their initial  re- 
sponse, after engagement of the BCR, is quite similar to that 
of B lymphoma cells (45) or normal B cells (31).  In partic- 
ular,  the same PTKs are activated,  and most FFK substrate 
proteins seem to be identical in these different B cells.  We 
have generated J558L myeloma transfectants  expressing similar 
amounts of antigen-specific IgM-BCR and/or IgD-BCR on 
the cell surface.  A functional analysis  of these transfectants 
shows that  the cross-linking  of the  IgD-BCR provokes a 
stronger and more long-lasting substrate phosphorylation than 
the cross-linking  of the  IgM-BCR. 
Materials  and  Methods 
Construction of the  Chimeric Heavy Chain Expression Vectors 
pSV712p4m andpSVT1283m.  A DNA fragment containing the 
C/~4 exon with a single Pst site was obtained by PCR using the 
oligos:  5'  CTTACACTCGAGTTGCAGGAC  and  3'  CTATAT- 
GTGTGCCTGAATGCT and the plasmid pSVul (46) as template 
DNA. The PCR fragment was cut by a XhoI and a HindlII and 
cloned into a variant of the plasmid pBS-KS lacking the Pst site 
in the polylinker. The Pst-HindlII  fragment of C/14 was replaced 
by the 1.1-kb Pst-HindlII  fragment "Ir obtained from the expres- 
sion vector pSV/~m5 (47). From this plasmid, we isolated the 1.5- 
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for the C/z4 domain, the transmembrane,  and the cytoplasmic parts 
of the/~m chain. The 1.3-kb BgllI-KpnI fragment 3,12 containing 
the C3,1, hinge, and C3,2 exons was obtained by PCR using DNA 
of the vector pG2am (22) as a template.  The 3.8-kb EcoRI-BamHI 
fragment containing the VH promotor, the VH exon, and the IgH 
enhancer +  V-promotor (EV) was described previously (48). The 
fragments EV, 3,12, and/~4m were then cloned into the EcoRI 
cut pSV2gpt plasmid to obtain the expression vector pSV3,12/z4m. 
The C81, hinge, and C83 exons reside on a 2.5-kb BgllI-KpnI 
fragment from which we isolated the 0.4-kb SalI-KpnI fragment 
63 containing the C83 exon of the 8 gene. By subcloning we changed 
the 1.4-kb  BamHI fragment carrying the two membrane exons 
of the 8 gene into the KpnI-EcoRI fragment 8m (48). The 1.3-kb 
3,12 fragment was obtained as the BgllI-SalI  fragment 3,12s. To 
generate the expression  vector pSV3,1283m,  we cloned the frag- 
ments EV, 3,12s, 83, and 8m into the EcoRI cut pSV2gpt plasmid. 
Cells.  J558L is a myeloma line which produces M  light chain, 
but no heavy chain (43). J558L/~m3 expresses mlgM in association 
with the Ig-cc/Ig-~ heterodimer (49). J558L/~m3/~n7 was made 
by the transfection of  J558L#m3 with an expression vector for the 
(Sin heavy chain (50). Cells were cultured in RPMI 1640 medium 
supplemented with  15%  FCS,  2  mM  glutamine,  5  x  10  -s M 
2-mercaptoethanol, and antibiotics  (100 U/ml of penicillin and 100 
#g/ml of streptomycin). 
Antibodies and Reagents.  The affinity-purified  antibodies:  rat 
anti-mouse IgD, goat anti-mouse IgM, and goat anti-mouse IgG, 
as well as their biotinylated, or FITC-coupled, counterparts and 
PE-coupled streptavidin,  were obtained from Southern Biotech- 
nology Associates Inc. (Birmingham, AL). The rat anti-mouse IgM 
mAb b7.6 and the rat anti-mouse IgD mAb 10.4.22 were provided 
by Dr.  M.  Lamers  (Max-Planck  Institute  for Immunobiology, 
Freiburg, Germany). The mouse anti-phosphotyrosine mAb 4G10 
was purchased from Upstate Biotechnology, Inc. (Lake Placid, NY). 
The antiidiotype mAb Ac146, the antigen NIP-coupled BSA 
(NIP10-BSA), and NIP-coupled Sepharose 4B beads were provided 
by Dr. K. Rajewsky (Institute for Genetics, University of Cologne, 
Germany). 
Su~ce Biotinylation.  Surface biotinylation was performed, as 
described  previously (16), with some modifications. Cells  (2  x 
107) were washed twice with PBS and incubated in 1 ml of PBS 
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Figure  1.  Expression  oflgM-BCR and IgD-BCR on the 
surface  of the J558L#m3/~m7 transfectant  and five  of its sub- 
clones. (A) The amount of IgM-BCR (ordinate) and IgD- 
BCR (abscissa) on the surface ofJ558L#m3/~n7 (a) and the 
subclones 7-14 (b), 7-7a (c), 7-7b (d), 7-6 (e), and 7-1 (f) was 
examined by two-color flow cytometry (FACScan  |  Becton 
Dickinson and Co., Mountain View, CA). The mlgM mole- 
cules were detected with a combination of biotinylated goat 
anti-mouse IgM and PE-coupled  streptavidin, while the mIgD 
molecules  were detected  with a combination  of rat anti-mouse 
IgD and FITC-coupled  anti-rat IgG antibody. (B) The total 
amount of BCR. expressed on the surface ofJ558L (a), and 
the subclones 7-14 (b), 7-7a (c), 7-7b (d), 7-6 (e), and 7-1 
was exaa'ained  by flow cytometry (FACScan|  The cells were 
stained with a combination  of the antiidiotypic  antibody  Ac146 
and FITC-coupled anti-mouse IgG. 
1007  Kim and Reth Figure  2.  Biochemical analysis of the IgM-BCR (lanes 1 and 2), IgD- 
BCR (lanes 3 and 4), and a chimeric IgM/D-BCR (lanes 5 and 6) on 
the surface of the subclones 7-14, 7-1, and the transfectant  J558L/z/$3m, 
respectively. Surface biotinylated receptors were purified over NIP-coupled 
Sepharose and analyzed by 10%  SDS-PAGE under reducing conditions. 
In lanes I, 3, and 5, the specific binding of the receptor to the affinity 
column was inhibited by 10 #g/ml of NIP-BSA. The biotinylated  proteins 
were detected on the Western blot by the horseradish peroxidase coupled 
streptavidin and the ECL system  (Amersham). 
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Figure  4.  Difference in the kinetic of tyrosine phosphorylation of the 
FTK substrate protein p65 in five subdones of  J558L/~m3/&,aT. The cells 
were incubated for the indicated times with 10/~g/ml of NIP10-BSA. 
Tyrosine-phosphorylated p65 was detected by Western blotting and the 
ECL system. The intensity of the p65 signal on the film was measured 
with a laser densitometer (2222-020, Ultrascan XL; Pharmacia LKB Bio- 
technology,  Inc., Uppsala, Sweden). The change in p65 phosphorylation 
is given as the ratio of absorbance before (Ao) and after (A) stimulation 
of the BCR for the indicated times. 
Chemical Co., Rockford, IL) at room temperature for 15 min. Free 
succinimide groups were blocked by the addition of 5 ml of non- 
supplemented medium at room temperature for 5 rain. The cells 
were washed twice with PBS and lysed in I  ml of ice-cold Triton 
X-100 lysis buffer. After incubation for 10 min on ice, the superna- 
tant was cleared by centrifugation at 10,000 g  for 10 rain at 4~ 
and specific mlg was precipitated with NiP-coupled Sepharose beads. 
Figure 3.  Comparison of the kinetics of FTK substrate phosphorylation  in stimulated IgM-BCK or IgD-BCK-expressing  B cells. The mlgM-producing 
subdone 7-14 (lanes 1-10) and the mlgD-producing subclone  7-1 (lanes 11-20)  were incubated for the indicated times,  either with 40/~g/ml of a 
one to one mixture of the anti-/x antibody b7.6 and the anti-~ antibody 10.4.22 (lanes 1-5, 11-15), or with 10/~g/ml of NIP10-BSA (lanes 6-10, 16-20). 
Tyrosine-phosphorylated  proteins were detected on the Western blot by the mAb 4G10. The positions of molecular weight markers (Kd) and of major 
substrate  proteins are indicated on the left and the right sides of the figure,  respectively. 
1008  The IgD B Cell Antigen Receptor Induces  a Prolonged Phosphorylation cleared  by centrifugation  at lO,O00g  for 10 min at 4~  and specific 
mlg was precipitated with NiP-coupled Sepharose beads. 
Detection  of Tyrosine  Phosphorylated  Proteins  by l~stern  Blotting.  Tyro- 
sine phosphorylated  proteins were  detected,  as previously  described 
(16, 45), with some modifications. 4 x  106 cells were resuspended 
in 0.5 ml of RPMI 1640 medium  and stimulated  in 24-well  culture 
plates. After washing twice with ice-cold  PBS containing 1 mM 
sodium orthovanadate  (Sigma Chemie GmbH, Deisenhofen,  Ger- 
many), cells were lysed with 100/~1 of Triton X-100 lysis buffer 
containing  20 mM Tris-HC1 (pH 8.0), 137 mM NaC1, 10% glycerol, 
1% Triton X-100, 2 mM EDTA, 10 #g/ml leupeptin (Sigma), 10 
/~g/ml aprotinin (Sigma), 1 mM PMSF (Sigma), and 1 mM so- 
dium orthovanadate.  After incubation  for 10 min on ice, the super- 
natant was cleared  by centrifugation  at lO,O00g  for 15 rain at 4~ 
Subsequently, 20/zl of supernatant was subjected to 12% SDS- 
PAGE and Western  blotting. The nitrocellulose  membrane  was in- 
cubated with the antiphosphotyrosine  mAb 4G10 (Upstate  Biotech- 
nology, Inc.) and with horseradish  peroxidase-coupled  anti-mouse 
Ig antibody  (Amersham  Buchler  GmbH, Braunschweig,  Germany). 
The bound antibodies  were  visualized  by the enhanced  chemilumi- 
nescence (ECL) detection system (Amersham). 
Results 
Characterization of Five Sub  clones of the Cell Line J558L/~ 
m3/dm-7 which Coexloress  mlgM and mlgD  The Ig-a-posi- 
tive Ig-transfectant  J558L/zm3  expresses large amounts of 
mlgM on the cell surface in association with the Ig-a/Ig-3 
heterodimer (49). The J558L#m3//~m-7 cell line was gener- 
ated by the transfection of J558L#m3 cells with an expres- 
sion vector encoding the mlgD heavy chain (50). Both the 
IgM and the IgD antigen receptors of the J558L#m3//~m-7 
cells bind the hapten NIP. A flow cytometric  analysis  revealed 
a heterogeneous expression of mlgM and mlgD on the sur- 
face of the J558L/zm3/~m-7  cells (Fig. 1 A, a). J558L/~m3/ 
6m-7 cells with strong mlgD expression had less mlgM on 
the cell surface, suggesting a competition of the two Ig classes 
for limiting quantities of the Ig-a/Ig-3 heterodimer or an- 
other as yet unknown factor. By cell sorting and/or limiting 
dilution we have isolated the five  subclones 7-14, 7-7a, 7-7b, 
7-6, and 7-1 (Fig. 1 A, b-J). Each of these subclones has a 
more homogeneous mlg expression than that of the parental 
population, and the phenotype is stable during prolonged 
culture of these cells. The subclone 7-7b has an intermediate 
expression of both classes whereas the subclones 7-14 and 
7-1 express almost exclusively  mlgM and mlgD, respectively. 
In spite of these differences, all subclones carry on their cell 
surfaces roughly the same amount of total mlg (Fig. 1 B) 
as detected by the antiidiotypic antibody Ac146 (51), which 
binds to the identical hapten binding site of the mlgM and 
mlgD molecules. 
The composition of the IgM antigen receptor on the cell 
surfaces of the subclones 7-14 and 7-1 was analyzed by sur- 
face biotinylation and the affinity purification of the receptor 
complexes over NIP-coupled Sepharose. The SDS-PAGE anal- 
ysis showed that the IgM-BCR (Fig. 2, lane 2) contained 
roughly the same amount of the Ig-ol/Ig-3 heterodimer as 
the IgD-BCR (Fig. 2, lane 4). The two receptor complexes 
differ, however, in the size of their Ig-c~ component, which 
is due to stronger glycosylation of the IgD-associated Ig-a 
(IgD-oe). The analysis of a chimeric antigen receptor (/z/~3m) 
showed that the more extensive glycosylation of IgD-a re- 
quires only the most membrane proximal C-domain and the 
transmembrane domain of the/~m heavy chain (Fig. 2, lane 6). 
Activation of  PTK by Cross-linking of mlgM and mlgD with 
Anti-Ig Antibodies or the Specific Antigen NIP1o-BSA.  The 
two J558L/zm3/g  subclones 7-14 and 7-1 were used to ana- 
lyze the activation of PTKs upon engagement of the IgM- 
and IgD-BCIL respectively.  The two subclones  were incubated 
for different lengths of time (1-240 rain) in the presence of 
either a mixture of the two monoclonal antibodies (mAb) 
10.4.22 (anti-IgD) and b7.6 (anti-IgM) (Fig. 3, lanes I-5 and 
11-15), or the polyvalent antigen NIP10-BSA (Fig. 3, lanes 
6-10 and 16-20). The PTK activation in these cells was moni- 
tored by the increase of tyrosine phosphorylation of PTK sub- 
strate proteins in total Triton X-100 cell lysates. The proteins 
p116, pS0, p66, p65, p55, p39, and p34 are major substrate 
proteins in Ig-transfectants of  J558L. The identities of most 
of these substrates are unknown at present, except those of 
p66, p39, and p34 which we have identified as PTK72/syk, 
Ig-3, and Ig-ol, respectively (45). Note that due to glycosy- 
lation differences, IgD-oe has a size (35 kD), which differs 
by I kD from that of IgM-oe. Cross-linking  the IgM-BCR 
or IgD-BCR, results in the phosphorylation of the same sub- 
strate proteins, but with a different intensity. The IgD-BCR 
induces a stronger phosphorylation than that of the IgM- 
BCR, especially when it is cross-linked by antigen (Fig. 3, 
lanes 16-20) rather than by anti-Ig antibody (Fig. 3, lanes 
11-15). Furthermore, the kinetics of phosphorylation differ 
between the two receptors. After the IgM-BCR were cross- 
linked, the substrate phosphorylation reached its maximum 
in 1 min and decreased  thereafter (Fig. 3, lanes 1-I0), A similar 
kinetic  has  also been found in  other mlgM-  or mlgG- 
expressing transfectants  of the myeloma line J558L  or the 
B lymphoma line K46 (22, 45). In contrast,  in the mlgD- 
producing cell 7-1, the substrate phosphorylation still increases 
after 1 min of stimulation and reaches a maximum 10 and 
60 min after cross-linking of the IgD-BCR with the anti-IgD 
antibody and the antigen NIP10-BSA, respectively. 
To exclude the possibility that the observed difference in 
PTK substrate phosphorylation was due to variation between 
transfectants rather than to the class of the BCR, we incubated 
all five  J558L#m3/&n7 subclones for varying times with the 
antigen NIP10-BSA. We then monitored by densitometry 
(Fig. 4) the increase in tyrosine phosphorylation of p65,  a 
substrate which becomes most rapidly and strongly phos- 
phorylated after  BCR cross-linking  (45). All IgD-BCR- 
expressing subclones showed a stronger and more persistent 
p65 phosphorylation than the IgM-BCR.-producing line 7-14. 
Indeed,  the two subclones (7-6 and 7-1) with the highest 
IgD-BCR expression, displayed the same intensity and ki- 
netics of p65 phosphorylation with a maximum 60 min after 
exposure to antigen. 
Cross-linking of  BCR with an Antiidiot~ic Antibody.  Cross- 
linking of the IgD-BCR with the antigen NIP10-BSA re- 
sulted in a stronger and more persistent substrate phosphory- 
1009  Kim and ILeth Figure 5.  Kinetics of tyrosine phosphorylation  of substrate proteins 
induced by the antiidiotype antibody Ac146. The mlgM-producing sub- 
clone 7-14 (lanes I-5) and the mlgD-producing subclone 7-1 (lanes 6-10) 
were incubated for the indicated times with 20/~g/ml of the antiidiotype 
antibody Ac146. Tyrosine-phosphorylated  proteins were detected  by Western 
blotting. Molecular weight markers (/Ca/) and the major substrate proteins 
are indicated on the left and right sides of the figure, respectively. 
lation than cross-linking with the monoclonal anti-IgD an- 
tibody. This could be due to the fact that the multivalent 
antigen NIP10-BSA can induce a larger BCR aggregation on 
the B cell surface than the divalent anti-IgD antibody. Alter- 
natively, this difference may be due to the different orienta- 
tions with which these two cross-linking reagents bind to 
the receptor. The anti-IgD antibody is directed against the 
CH1 domain and should bind the BCR from the side, whereas 
the antigen is occupying the hapten-binding  site at the top 
of the receptor. To distinguish  between these possibilities, 
we used the antiidiotypic antibody Ac146 as a cross-linking 
reagent. The binding of Ac146 to the BCR is inhibited by 
the free hapten NIP-cap (51). The antibody Ac146 is, thus, 
complementary  to the hapten-binding  site and should cross- 
link  the BCR  with  the  same orientation as  the antigen 
NIP10-BSA, but divalently. Cross-linking  the mlgD-BCR. 
with Ac146 resulted in a strong PTK substrate phosphoryla- 
tion, which reached its maximum at 60 min (Fig. 5, lanes 
6-10) and, thus, was similar to the phosphorylation invoked 
by antigen.  This result  indicates that not only the extent, 
but also the mode of cross-linking,  is influencing the sig- 
naling output from the IgD-BCR.. Engagement of the IgM- 
BCR with Ac146 resulted in a PTK substrate phosphoryla- 
tion which reached its maximum at 1 min (Fig. 5, lanes I-5), 
stressing again the difference in signal transduction from the 
two classes of antigen receptors upon exposure to the same 
cross-linking reagent. 
Analysis of Chimeric BCRs with the Membrane Proximal C 
Domain and  the  Transmembrane Region of Either mlgD  or 
mlgM.  The mlgD and mlgM molecules expressed on the 
surfaces ofJ558L transfectants possess the same light chain 
and the same variable domain of  VH but differ in their heavy 
chain constant and transmembrane regions. The constant re- 
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Figure 6.  Expression of the chimerica IgG/M-BCR and IgG/D-BCR on the cell surface ofJ558L  myeloma transfectants. (A) Domain architecture 
of the chimeric mlgG/M and mlgG/D molecules. The membrane proximal CH domain +  transmembrane region of the/~m and 6m chain are drawn 
as white and black squares, respectively. The NH2-terminal  domains of the y2a heavy chain and the two domains of the light chain are shown as 
grey and dark striped boxes, respectively. (B) The cell lines J558L3~12#4m/mb-1 and J558L3q263m/mb-1  were transfected with the chimeric heavy 
chain expression vectors pSV3,12#4m and pSVy1263m, respectively. The transfectants were incubated with F1TC-coupled anti-mouse IgG antibodies 
and the amount of chimeric receptors on the surface of these cells determined by flow r  (FACScan|  Untransfected J558L cells were analyzed 
as controls in parallel. 
1010  The IgD B Cell Antigen Receptor  Induces a Prolonged  Phosphorylation gion of the #m chain contains four C domains (Cgl-Cg4), 
whereas the murine 8m chain contains two C domains (C81 
and C83)  separated by a long hinge region.  To determine 
whether these differences in the composition of the C  do- 
mains are responsible for the different signaling kinetic of 
the IgM- and IgD-BCK, we constructed the expression vectors 
pSV3,12/x4m and pSV3'1283m.  These vectors encode chimeric 
heavy chains consisting of the NiP-specific VH domain, the 
CH1 and CH2 domains of the q/2a heavy chain followed by 
the membrane proximal CH domain C#4 or C83,  and the 
transmembrane region of either gm or dim. The assembly 
of the chimeric heavy chains with  the X1 light chain and 
the Ig-ot/Ig-/3 heterodimer results in the expression of an- 
tigen receptors with identical overall domain architecture (Fig. 
6  a).  The  two  chimeric BCRs  are expressed  on  the  cell 
surfaces  of  the  transfectants  J558Ly12#4m/mb-1  and 
J558Ly1283m/mb-1 in similar amounts (Fig.  6 B). Incuba- 
tion of J558L'y1283m/mb-1 ceils with 10 gg of the NIP10- 
BSA for various times resulted in a PTK substrate phosphory- 
lation which reached its maximum at 10 min and persisted 
well over 240 min (Fig.  7, lanes 6-10).  Under the same ex- 
perimental condition, the PTK substrate phosphorylation in 
J558L3d2#4m/mb-1 cells reached its maximum in 1 min and 
declined after 60 min (Fig.  7, lanes 1-5).  A  similar kinetic 
of substrate phosphorylation was  observed when the two 
different transfectants were incubated with an anti-IgG an- 
Figure 7.  Kinetics  of tyrosine  phosphorylation  of substrate proteins 
induced by the antigen-mediated  cross-linking  of the chimeric  IgG/M- 
BCR and IgG/D-BCK. The transfectants  J558L3'1294m/mb-1 (lanes  I-5) 
and  J558L3d283m/mb-1  (lanes  6-10) were  incubated  for the indicated  times 
with 10/~g/ml  of  NIP10-BSA. Tyrosine-phosphorylated  proteins  were  de- 
tected  by Western  blotting. Molecular  weight  markers  (Kd)  and the major 
substrate  proteins  are indicated  on the left  and the fight sides  of  the figures, 
respectively. 
tiserum instead of antigen (data not shown). Thus, although 
the chimeric IgD- and IgM-BCRs induce a less intensive tyro- 
sine phosphorylation than their wild-type receptors. This result 
shows that the sequence differences in the membrane prox- 
imal C  domain and/or transmembrane region, rather than 
the different C domain architecture, is responsible for the sig- 
naling differences between IgM-  and IgD-BCR. 
Discussion 
Our analysis of B cell lines carrying the IgM-BCR or IgD- 
BCR with the same antigen specificity showed that, while 
the initial response from these receptors is quite similar,  the 
duration of this response differs between the two receptors. 
More specifically, cross-linking of both receptors results in 
the activation of the same lYl'Ks as indicated by the phos- 
phorylation of the same substrate proteins. The phosphory- 
lation induced via the IgM-BCR, however, reaches its max- 
imum  1 min  after exposure to  antigen  and declines soon 
thereafter, whereas under the continuous exposure to antigen, 
IgD-BCR remains active and can signal for a prolonged period. 
This finding may shed light on the ongoing controversy 
whether or not these two classes of BCR differ in their signal 
transduction capabilities.  It has been shown that the early 
events in signal transduction like the PTK activation (31, 32, 
37)  and the release  of Ca  2§  ion  (52)  are quite  similar be- 
tween the two receptors. However, the cellular responses of 
activated B cells, such as tolerance induction, apoptosis,  or 
interleukin secretion, can be quite different depending on 
whether the cells were stimulated via the IgM-BCR or the 
IgD-BCR. Specifically, engagement of IgM on immature B 
cells results in their deletion, whereas engagement of the IgD- 
BCR on these cells does not have this effect (40).  Similarly, 
data from 8m-transfectants of the WEHI231 (36) or CH33 
(53) cell lines showed that cross-linking of the IgM-BCR, 
but not of the IgD-BCR., can activate an apoptosis program 
in these cells.  It is conceivable that the apoptotic pathway 
in these B cells is inhibited by the more prolonged PTK ac- 
tivity which we have detected after engagement of the IgD- 
BCR.  Recently, Roes and Rajewsky (41) reported that,  in 
mlgD knockout mice, the production of high affinity anti- 
bodies against T  cell-dependent antigens is delayed in the 
early primary response.  The long-lasting signals  from the 
mlgD-BCR may, therefore, also be required for the efficient 
selection of high affinity B cells. 
The different behavior of the IgM and IgD antigen receptors 
on B cell lines is reminiscent of that which is observed in 
tyrosine kinase receptors (TKR) on the neuronal cell line PC12. 
These cells express two types of TKR, namely the epidermal 
growth factor receptor (EGFR) and the neuronal growth factor 
receptor (NGFR). Signal transduction from the two receptors 
involves the same signaling pathway; yet, the outcome of this 
signal is different, resulting either in growth or in neural 
differentiation. How the two receptors could achieve these 
differential responses was a puzzle (54).  Two recent publica- 
tions (55,  56) provide an answer to this riddle by showing 
that the activation of the NGFR results in a stronger and 
more prolonged microtubule-associated protein 2 kinase ac- 
1011  KimandReth tivation than that resulting from the activation of the EGFR. 
Furthermore, after overexpression of the EGFR or mutation 
of serines  in the cytoplasmic part of the EGFR involved in 
feedback regulation the signal from this receptor no longer 
resulted in growth but in the neuronal differentiation  of PC12, 
thus  giving  the  same result  as signal  transduction  via the 
NGFR. These experiments dearly demonstrate that  an in- 
crease  and prolongation  of signals  can dictate the outcome 
of the signal. 
The different kinetics of PTK activity observed in IgM- 
BCR or IgD-BCR-expressing B cells cultured in the pres- 
ence of antigen suggest that the IgM-BCR and the IgD-BCR 
are  under  a different feedback control.  Such a control can 
operate either via the downmodulation of the receptor and/or 
via the silencing of the receptor. A flow cytometric analysis 
ofJ558L transfectants cultured for 2 h in the presence of an- 
tigen showed a similar (three- to fivefold) reduction of the 
IgM-BCR as well as of the IgD-BCR on the surface of~:hese 
cells (data not shown). The differences in signal transduction 
from the  two classes of BCR are,  therefore,  not  due to a 
preferential  downmodulation  of one of the two receptors. 
This leaves the silencing of the IgM-BCR as a possible mech- 
anism for the short-term activation of this receptor. The mo- 
lecular details of this silencing process are not clear at present. 
It is possible that the serine/threonine phosphorylation which 
occurs at  the cytoplasmic tail of Ig-a  and Ig-/3  (57) is in- 
volved in this process. A model for such a feedback regula- 
tion is the TKR c-kit and EGFR whose signal emission is 
altered by protein kinase C-mediated serine phosphorylation 
(58,  59). 
Our data could be explained by a scenario whereby antigen- 
mediated cross-linking of the IgM-BCR results in a defined 
BCR aggregation, which allows the signaling and silencing 
process to operate, whereas the aggregated IgD-BCR can ac- 
tivate only the former process. How the two BCRs which 
have identical cytoplasmic parts can form functionally different 
aggregates remains to be elucidated. By the study of chimeric 
BCRs, we have excluded the possibility that the different do- 
main architecture of the 6m and/zm heavy chain is respon- 
sible for this different behavior,  and have  shown that  only 
the last (membrane proximal)  C  domain and/or the trans- 
membrane domain is required for the class-specific function 
of these receptors. The same structures have previously been 
implicated as contact sites between the heavy chain and the 
Ig-ot/Ig-/3 heterodimer.  It is, thus, possible that mlgM and 
mlgD interacts in different ways with the Ig-c~/Ig-fl hetero- 
dimer and that this alters the aggregation and signal trans- 
duction of the two receptors.  Alternatively,  proteins other 
than Ig-oL and Ig-/3 may interact with the two BCRs in a 
class-specific manner and influence their signal transduction. 
Recently,  four  new  BC1K-associated  proteins  (BAP)  were 
identified (48, 60): BAP37 and BAP32, which are exclusively 
associated with the mlgM molecule, and BAP29 and BAP31, 
which are preferentially associated with the mlgD molecule. 
These novel membrane proteins are associated with the trans- 
membrane part of the mlgM or mlgD molecule. At present, 
however, it is not clear whether the BAP/mlg complexes are 
formed only intracellularly or also on the cell surface.  If the 
latter is true, the BAPs may influence the signal transduction 
from the BCR in a class-specific  manner. 
The functional difference between the IgM-BCR and IgD- 
BCR is more obvious when the two receptors are cross-linked 
by antigen or antiidiotypic antibody than by class-specific an- 
tibodies. This may be the reason why these differences have 
remained undetected so far since most previous studies used 
the latter reagents. Our results are in line with studies from 
other receptors which show that most antireceptor antibodies 
can only imperfectly mimic the ligand-receptor  interaction 
(61). Apparently, for efficient signal induction to occur, the 
BCR has to be cross-linked with a precise orientation.  For 
the antigen or for idiotype-speciflc antibodies which bind the 
receptor from the top, this criterium may be easier  to fulfill 
than for isotype-specific antibodies which bind the receptor 
from the side. Indeed, from the three anti-6 mAb we tested, 
only one was able to cross-link the IgD-BCR in such a way 
that PTKs were induced. Clearly, more remains to be learned 
about the precise topology of the signal-emitting BCR ag- 
gregate and about the differences between the IgM-BCR and 
IgD-BCR complexes. 
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